CEACAM5 and colorectal cancer: During malignant transformation, sLea but also sLex, become expressed on the glycoprotein CEA (carcinoembryonic antigen) [109,110], which is currently undergoing clinical translation facilitated by our group as a target for NIRF imaging of colorectal cancer (SGM-101, SurgiMab) [111].